DNA methylation is altered in maternal blood vessels of women with preeclampsia

Reproductive Sciences

Volumn 19, Issue 12, 2012, Pages 1332-1342

  Mousa, Ahmad A ^a   Archer, Kellie J ^a   Cappello, Renato ^a   Estrada Gutierrez, Guadalupe ^a,b   Isaacs, Christine R ^a   Strauss, Jerome F ^a   Walsh, Scott W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

DNA methylation; epigenetics; inflammation.; omental blood vessels; preeclampsia

Indexed keywords

BISULFITE; DNA; DNA METHYLTRANSFERASE;

ADULT; ARTICLE; ASSAY; BIOPSY; BLOOD VESSEL; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEMALE; HUMAN; INFLAMMATION; OMENTUM; PATHOGENESIS; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; X CHROMOSOME INACTIVATION;

ADULT; AMINO ACIDS; ARTERIES; CARBOHYDRATE METABOLISM; DNA METHYLATION; EPIGENESIS, GENETIC; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INFLAMMATION; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; OMENTUM; OXIDATION-REDUCTION; PRE-ECLAMPSIA; PREGNANCY; THROMBOSIS;

EID: 84868556338     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719112450336     Document Type: Article

References (76)

1. Cunningham FG, Leveno KJ, Bloom SL, Gilstrap III LC, Hauth JC, Wenstrom KD Williams Obstetrics. 22 nd ed. New York, NY: McGraw-Hill; 2005. New York, NY: McGraw-Hill ; 2005 :
2. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension. 2005 ; 46 (6). 1243-1249
3. Pridjian G, Puschett JB. Preeclampsia. Part 2: experimental and genetic considerations. Obstet Gynecol Surv. 2002 ; 57 (9). 619-640
4. Williams PJ, Pipkin FB. The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best practice & research. Clin obstet Gynaecol. 2011 ; 25 (4). 405-417
5. Wilson CB, Makar KW, Shnyreva M, Fitzpatrick DR. DNA methylation and the expanding epigenetics of T cell lineage commitment. Semin Immunol. 2005 ; 17 (2). 105-119
6. Fraga MF, Esteller M. Epigenetics and aging: the targets and the marks. Trends Genet. 2007 ; 23 (8). 413-418
7. Tost J. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. Mol Biotechnol. 2010 ; 44 (1). 71-81
8. Franco R, Schoneveld O, Georgakilas AG, Panayiotidis MI. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett. 2008 ; 266 (1). 6-11
9. Zaina S, Lindholm MW, Lund G. Nutrition and aberrant DNA methylation patterns in atherosclerosis: more than just hyperhomocysteinemia?. J Nutr. 2005 ; 135 (1). 5-8
10. Paulsen M, Ferguson-Smith AC. DNA methylation in genomic imprinting, development, and disease. J Pathol. 2001 ; 195 (1). 97-110
11. Agrawal A, Murphy RF, Agrawal DK. DNA methylation in breast and colorectal cancers. Mod Pathol. 2007 ; 20 (7). 711-721
12. Connor CM, Akbarian S. DNA methylation changes in schizophrenia and bipolar disorder. Epigenetics. 2008 ; 3: 55-58
13. van der Linden IJ, Heil SG, van Egmont Petersen M, van Straaten HW, den Heijer M, Blom HJ. Inhibition of methylation and changes in gene expression in relation to neural tube defects. Birth Defects Res A Clin Mol Teratol. 2008 ; 82 (10). 676-683
14. Dong C, Yoon W, Goldschmidt-Clermont PJ.. DNA methylation and atherosclerosis. J Nutr. 2002 ; 132: 2406S - 2409
15. Baccarelli A, Wright R, Bollati V, Litonjua A, Zanobetti A, Tarantini L, Sparrow D, Vokonas P, Schwartz J. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology. 2010 ; 21 (6). 819-828
16. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med. 1999 ; 222 (3). 222-235
17. Walsh SW. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol. 1998 ; 16 (1). 93-104
18. Walsh SW. Obesity: a risk factor for preeclampsia. Trends in endocrinology and metabolism: TEM. 2007 ; 18 (10). 365-370
19. Wang JX, Knottnerus AM, Schuit G, Norman RJ, Chan A, Dekker GA. Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia. Lancet. 2002 ; 359 (9307). 673-674
20. Yu L, Chen M, Zhao D, et al. The H19 gene imprinting in normal pregnancy and pre-eclampsia. Placenta. 2009 ; 30 (5). 443-447
21. Chelbi ST, Vaiman D. Genetic and epigenetic factors contribute to the onset of preeclampsia. Mol Cell Endocrinol. 2008 ; 282 (1-2). 120-129
22. Chelbi ST, Mondon F, Jammes H, et al. Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia. Hypertension. 2007 ; 49 (1). 76-83
23. Kanayama N, Takahashi K, Matsuura T, et al. Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol Hum Reprod. 2002 ; 8 (12). 1129-1135
24. Yuen RK, Penaherrera MS, von Dadelszen P, McFadden DE, Robinson WP. DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia. Eur J Hum Genet. 2010 ; 18 (9). 1006-1012
25. Clark SJ, Statham A, Stirzaker C, Molloy PL, Frommer M. DNA methylation: bisulphite modification and analysis. Nat Protoc. 2006 ; 1: 2353-2364
26. Grunau C, Clark SJ, Rosenthal A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res. 2001 ; 29 (13). E65-5
27. Xiong Z, Laird PW. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 1997 ; 25 (12). 2532-2534
28. Wang H, Ogawa M, Wood JR, et al. Genetic and epigenetic mechanisms combine to control MMP1 expression and its association with preterm premature rupture of membranes. Hum Mol Genet. 2008 ; 17 (8). 1087-1096
29. Bibikova M, Lin Z, Zhou L, et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res. 2006 ; 16 (3). 383-393
30. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003 ; 100 (16). 9440-9445
31. Weisenberger DJ, Berg DVD., Pan F, Berman BP, Laird PW Comprehensive DNA Methylation Analysis on the Illumina Infinium Assay Platform. San Diego, CA: Illumina and Inc ; 2008 :
32. Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell. 2007 ; 128 (4). 707-719
33. Archer KJ, Mas VR, Maluf DG, Fisher RA. High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma. Mol Genet Genomics. 2010 ; 283 (4). 341-349
34. Tanabe T, Ullrich V. Prostacyclin and thromboxane synthases. J Lipid Mediat Cell Signal. 1995 ; 12: 243-255
35. Walsh SW. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol. 1985 ; 152 (3). 335-340
36. Chavarria ME, Lara-Gonzalez L, Gonzalez-Gleason A, Garcia-Paleta Y, Vital-Reyes VS, Reyes A. Prostacyclin/thromboxane early changes in pregnancies that are complicated by preeclampsia. Am J Obstet Gynecol. 2003 ; 188 (4). 986-992
37. Mills JL, DerSimonian R, Raymond E, et al. Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. JAMA. 1999 ; 282 (4). 356-362
38. Walsh SW. Eicosanoids in preeclampsia. Prostaglandins Leukot Essent Fatty Acids. 2004 ; 70: 223-232
39. Mousa AA, Strauss III JF, Walsh SW. Reduced methylation of thromboxane synthase gene is correlated with its increased vascular expression in preeclampsia. Hypertension. 2012 ; 59 (6). 1249-1255
40. Estrada-Gutierrez G, Cappello RE, Mishra N, Romero R, Strauss JF, Walsh SW. Increased expression of matrix metalloproteinase-1 in systemic vessels of preeclamptic women: a critical mediator of vascular dysfunction. Am J Pathol. 2011 ; 178 (1). 451-460
41. Cappello R, Estrada-Gutierrez G, Gerk PM, Strauss III JF, Walsh SW.. Epigenetic control of collagen regulating genes in vascular smooth muscle. Reprod Sci. 2008 ;:
42. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999 ; 180 (2 pt 1). 499-506
43. Gatti L, Tenconi PM, Guarneri D, et al. Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy: a longitudinal study. Int J Clin Lab Res. 1994 ; 24 (4). 217-219
44. Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol. 1994 ; 101 (6). 488-492
45. Haram K, Augensen K, Elsayed S. Serum protein pattern in normal pregnancy with special reference to acute-phase reactants. Br J Obstet Gynaecol. 1983 ; 90 (2). 139-145
46. Austgulen R, Lien E, Liabakk NB, Jacobsen G, Arntzen KJ. Increased levels of cytokines and cytokine activity modifiers in normal pregnancy. Eur J Obstet Gynecol Reprod Biol. 1994 ; 57 (3). 149-155
47. Melczer Z, Banhidy F, Csomor S, et al. Influence of leptin and the TNF system on insulin resistance in pregnancy and their effect on anthropometric parameters of newborns. Acta Obstet Gynecol Scand. 2003 ; 82 (5). 432-438
48. Arntzen KJ, Liabakk NB, Jacobsen G, Espevik T, Austgulen R. Soluble tumor necrosis factor receptor in serum and urine throughout normal pregnancy and at delivery. Am J Reprod Immunol. 1995 ; 34 (3). 163-169
49. Lurie S, Rahamim E, Piper I, Golan A, Sadan O. Total and differential leukocyte counts percentiles in normal pregnancy. Eur J Obstet Gynecol Reprod Biol. 2008 ; 136 (1). 16-19
50. Barriga C, Rodriguez AB, Ortega E. Increased phagocytic activity of polymorphonuclear leukocytes during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1994 ; 57 (1). 43-46
51. Smarason AK, Gunnarsson A, Alfredsson JH, Valdimarsson H. Monocytosis and monocytic infiltration of decidua in early pregnancy. J Clin Lab Immunol. 1986 ; 21 (1). 1-5
52. Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998 ; 179 (1). 80-86
53. Barden A. Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol. 1999 ; 106 (11). 1232
54. Martin U, Davies C, Hayavi S, Hartland A, Dunne F. Is normal pregnancy atherogenic?. Clin Sci (Lond). 1999 ; 96 (4). 421-425
55. Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med. 2006 ; 11 (5). 309-316
56. Plutzky J. The PPAR-RXR transcriptional complex in the vasculature: energy in the balance. Circ Res. 2011 ; 108 (8). 1002-1016
57. Shah TJ, Walsh SW.. Activation of NF-kappaB and expression of COX-2 in association with neutrophil infiltration in systemic vascular tissue of women with preeclampsia. Am J Obstet Gynecol. 2007 ; 196 (1). e1-8
58. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005 ; 5 (4). 331-342
59. Yu M, Wang H, Ding A, et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock. 2006 ; 26 (2). 174-179
60. Inoue K, Kawahara K, Biswas KK, et al. HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques. Cardiovasc Pathol. 2007 ; 16 (3). 136-143
61. Mihu D, Costin N, Mihu CM, Blaga LD, Pop RB. C-reactive protein, marker for evaluation of systemic inflammatory response in preeclampsia. Rev Med Chir Soc Med Nat Iasi. 2008 ; 112 (4). 1019-1025
62. Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertens. 2004 ; 17 (2). 154-160
63. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffredini AF. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 2003 ; 101 (7). 2652-2660
64. Leik CE, Walsh SW. Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia. Hypertension. 2004 ; 44: 72-77
65. Narumiya H, Zhang Y, Fernandez-Patron C, Guilbert LJ, Davidge ST. Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia. Hypertens Pregnancy. 2001 ; 20 (2). 185-194
66. Poon LC, Nekrasova E, Anastassopoulos P, Livanos P, Nicolaides KH. First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome. Prenat Diagn. 2009 ; 29 (6). 553-559
67. Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol. 2002 ; 283 (1). R29-45
68. Lunell NO, Nylund LE, Lewander R, Sarby B. Uteroplacental blood flow in pre-eclampsia measurements with indium-113m and a computer-linked gamma camera. Clin Exp Hypertens B. 1982 ; 1 (1). 105-117
69. Perry KG., Martin JN,. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia. Clin Obstet Gynecol. 1992 ; 35 (2). 338-350
70. von Versen-Hoeynck FM, Powers RW. Maternal-fetal metabolism in normal pregnancy and preeclampsia. Front Biosci. 2007 ; 12: 2457-2470
71. Hill LD, York TP, Kusanovic JP, et al. Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia. PloS one. 2011 ; 6 (1). e16681
72. Hitchler MJ, Domann FE. An epigenetic perspective on the free radical theory of development. Free Radic Biol Med. 2007 ; 43 (7). 1023-1036
73. Weitzman SA, Turk PW, Milkowski DH, Kozlowski K. Free radical adducts induce alterations in DNA cytosine methylation. Proc Natl Acad Sci U S A. 1994 ; 91 (4). 1261-1264
74. Mishra N, Nugent WH, Mahavadi S, Walsh SW. Mechanisms of enhanced vascular reactivity in preeclampsia. Hypertension. 2011 ; 58 (5). 867-873
75. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007 ; 335 (7627). 974
76. Wen SW, Chen XK, Rodger M, et al. Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol. 2008 ; 198 (1). e1-7